Literature DB >> 24705722

The Pseudomonas aeruginosa exoenzyme Y impairs endothelial cell proliferation and vascular repair following lung injury.

Trevor C Stevens1, Cristhiaan D Ochoa2, K Adam Morrow3, Matthew J Robson4, Nutan Prasain5, Chun Zhou4, Diego F Alvarez6, Dara W Frank7, Ron Balczon8, Troy Stevens6.   

Abstract

Exoenzyme Y (ExoY) is a Pseudomonas aeruginosa toxin that is introduced into host cells through the type 3 secretion system (T3SS). Once inside the host cell cytoplasm, ExoY generates cyclic nucleotides that cause tau phosphorylation and microtubule breakdown. Microtubule breakdown causes interendothelial cell gap formation and tissue edema. Although ExoY transiently induces interendothelial cell gap formation, it remains unclear whether ExoY prevents repair of the endothelial cell barrier. Here, we test the hypothesis that ExoY intoxication impairs recovery of the endothelial cell barrier following gap formation, decreasing migration, proliferation, and lung repair. Pulmonary microvascular endothelial cells (PMVECs) were infected with P. aeruginosa strains for 6 h, including one possessing an active ExoY (PA103 exoUexoT::Tc pUCPexoY; ExoY(+)), one with an inactive ExoY (PA103ΔexoUexoT::Tc pUCPexoY(K81M); ExoY(K81M)), and one that lacks PcrV required for a functional T3SS (ΔPcrV). ExoY(+) induced interendothelial cell gaps, whereas ExoY(K81M) and ΔPcrV did not promote gap formation. Following gap formation, bacteria were removed and endothelial cell repair was examined. PMVECs were unable to repair gaps even 3-5 days after infection. Serum-stimulated growth was greatly diminished following ExoY intoxication. Intratracheal inoculation of ExoY(+) and ExoY(K81M) caused severe pneumonia and acute lung injury. However, whereas the pulmonary endothelial cell barrier was functionally improved 1 wk following ExoY(K81M) infection, pulmonary endothelium was unable to restrict the hyperpermeability response to elevated hydrostatic pressure following ExoY(+) infection. In conclusion, ExoY is an edema factor that chronically impairs endothelial cell barrier integrity following lung injury.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  cyclase; microtubules; permeability; pulmonary edema; tau

Mesh:

Substances:

Year:  2014        PMID: 24705722      PMCID: PMC4025060          DOI: 10.1152/ajplung.00135.2013

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  32 in total

1.  Microtubule disassembly increases endothelial cell barrier dysfunction: role of MLC phosphorylation.

Authors:  A D Verin; A Birukova; P Wang; F Liu; P Becker; K Birukov; J G Garcia
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-09       Impact factor: 5.464

2.  Coordinate regulation of membrane cAMP by Ca2+-inhibited adenylyl cyclase and phosphodiesterase activities.

Authors:  Judy R Creighton; Nanako Masada; Dermot M F Cooper; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-01       Impact factor: 5.464

3.  Cell cycle dependent distribution of the proliferation-associated Ki-67 antigen in human embryonic lung cells.

Authors:  N Braun; T Papadopoulos; H K Müller-Hermelink
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1988

4.  Ca(2+)-inhibitable adenylyl cyclase modulates pulmonary artery endothelial cell cAMP content and barrier function.

Authors:  T Stevens; Y Nakahashi; D N Cornfield; I F McMurtry; D M Cooper; D M Rodman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

Review 5.  The adenylate cyclase toxins.

Authors:  Nidhi Ahuja; Praveen Kumar; Rakesh Bhatnagar
Journal:  Crit Rev Microbiol       Date:  2004       Impact factor: 7.624

6.  Identification of nuclear tau isoforms in human neuroblastoma cells.

Authors:  P A Loomis; T H Howard; R P Castleberry; L I Binder
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

7.  Paradoxical cAMP-induced lung endothelial hyperpermeability revealed by Pseudomonas aeruginosa ExoY.

Authors:  Sarah L Sayner; Dara W Frank; Judy King; Hairu Chen; John VandeWaa; Troy Stevens
Journal:  Circ Res       Date:  2004-06-10       Impact factor: 17.367

8.  Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells.

Authors:  S H Leppla
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

9.  Secretion of cyclolysin, the calmodulin-sensitive adenylate cyclase-haemolysin bifunctional protein of Bordetella pertussis.

Authors:  P Glaser; H Sakamoto; J Bellalou; A Ullmann; A Danchin
Journal:  EMBO J       Date:  1988-12-01       Impact factor: 11.598

10.  Pseudomonas aeruginosa exotoxin Y-mediated tau hyperphosphorylation impairs microtubule assembly in pulmonary microvascular endothelial cells.

Authors:  Ron Balczon; Nutan Prasain; Cristhiaan Ochoa; Jason Prater; Bing Zhu; Mikhail Alexeyev; Sarah Sayner; Dara W Frank; Troy Stevens
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

View more
  38 in total

1.  cCMP and cUMP occur in vivo.

Authors:  Heike Bähre; Christina Hartwig; Antje Munder; Sabine Wolter; Tane Stelzer; Bastian Schirmer; Ulrike Beckert; Dara W Frank; Burkhard Tümmler; Volkhard Kaever; Roland Seifert
Journal:  Biochem Biophys Res Commun       Date:  2015-03-31       Impact factor: 3.575

2.  p18, a novel adaptor protein, regulates pulmonary endothelial barrier function via enhanced endocytic recycling of VE-cadherin.

Authors:  Havovi Chichger; Huetran Duong; Julie Braza; Elizabeth O Harrington
Journal:  FASEB J       Date:  2014-11-17       Impact factor: 5.191

Review 3.  Inflammation: A Double-Edged Sword in the Response to Pseudomonas aeruginosa Infection.

Authors:  Christina K Lin; Barbara I Kazmierczak
Journal:  J Innate Immun       Date:  2017-02-22       Impact factor: 7.349

4.  Pseudomonas aeruginosa infection liberates transmissible, cytotoxic prion amyloids.

Authors:  Ron Balczon; K Adam Morrow; Chun Zhou; Bradley Edmonds; Mikhail Alexeyev; Jean-Francois Pittet; Brant M Wagener; Stephen A Moser; Silas Leavesley; Xiangming Zha; Dara W Frank; Troy Stevens
Journal:  FASEB J       Date:  2017-03-17       Impact factor: 5.191

Review 5.  The Pseudomonas aeruginosa Exoenzyme Y: A Promiscuous Nucleotidyl Cyclase Edema Factor and Virulence Determinant.

Authors:  K Adam Morrow; Dara W Frank; Ron Balczon; Troy Stevens
Journal:  Handb Exp Pharmacol       Date:  2017

6.  Determinants for persistence of Pseudomonas aeruginosa in hospitals: interplay between resistance, virulence and biofilm formation.

Authors:  S J Kaiser; N T Mutters; A DeRosa; C Ewers; U Frank; F Günther
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-12       Impact factor: 3.267

7.  Lipopolysaccharide-induced pulmonary endothelial barrier disruption and lung edema: critical role for bicarbonate stimulation of AC10.

Authors:  Jordan Nickols; Boniface Obiako; K C Ramila; Kevin Putinta; Sarah Schilling; Sarah L Sayner
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-10-16       Impact factor: 5.464

8.  Endothelial Hypoxia-Inducible Factor-1α Is Required for Vascular Repair and Resolution of Inflammatory Lung Injury through Forkhead Box Protein M1.

Authors:  Xiaojia Huang; Xianming Zhang; David X Zhao; Jun Yin; Guochang Hu; Colin E Evans; You-Yang Zhao
Journal:  Am J Pathol       Date:  2019-05-20       Impact factor: 4.307

9.  Heterogeneity of pulmonary endothelial cyclic nucleotide response to Pseudomonas aeruginosa ExoY infection.

Authors:  K A Morrow; R Seifert; V Kaever; A L Britain; S L Sayner; C D Ochoa; E A Cioffi; D W Frank; T C Rich; T Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-18       Impact factor: 5.464

10.  α-Tocopherol Attenuates the Severity of Pseudomonas aeruginosa-induced Pneumonia.

Authors:  Brant M Wagener; Naseem Anjum; Cilina Evans; Angela Brandon; Jaideep Honavar; Judy Creighton; Maret G Traber; Robert L Stuart; Troy Stevens; Jean-Francois Pittet
Journal:  Am J Respir Cell Mol Biol       Date:  2020-08       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.